New Approaches in Educational Management and Health Sciences

New Approaches in Educational Management and Health Sciences

Study of Drug Loading and Evaluation of Bioactivity of Calcium Phosphate and Titanium Dioxide Nanotube Composite

Document Type : Original Article

Authors
Seyed Peiman Ghorbanzade Zaferani 1
Oveis Saneei Siavashy 2
1 University of Science and Technology of Mazandaran, P.O. Box 48518-78195, Behshahr, Iran.
2 University of Science and Technology of Mazandaran, P.O. Box 48518-78195, Behshahr, Iran
10.22034/edus.2026.236563
Abstract
One of the main solutions for eliminating various bone and cartilage defects is the use of various biomaterials such as implants and scaffolds. A layer of hydroxyapatite, which is one of the main components of bone, is created, which creates a bond between this biomaterial and the body's natural bone. Other applications of bioactive glasses include its use as a drug carrier. By loading antibiotics onto the glass used in damaged tissue and controlled release, possible infections in the graft area can be prevented. In this study, a bioactive nanocomposite consisting of bioactive glass and titanium dioxide nanotubes with nanoparticle concentrations of 5 and 15% was synthesized by the sol-gel method. Next, the bioactive properties, morphology, particle size, crystal structure and drug loading rate on the nanocomposites were investigated. In vitro bioactivity test was performed by immersing the samples in simulated body fluid for 28 days and considering the formation of hydroxyapatite layer on the surface of the samples. The results of the in vitro bioactivity test indicated the bioactivity of all synthesized samples. Among the available samples, the nanoglass containing 5% titanium dioxide nanotubes was the best. This nanoglass also showed the best performance in the drug loading test.
Keywords
Bioactive glass
drug
hydroxyapatite
titanium dioxide
1.             Kupjetz M, Joisten N, Rademacher A, Gonzenbach R, Bansi J, Zimmer P. Cycling in primary progressive multiple sclerosis (CYPRO): study protocol for a randomized controlled superiority trial evaluating the effects of high-intensity interval training in persons with primary progressive multiple sclerosis. BMC Neurol. 2023;23(1):162. doi: 10.1186/s12883-023-03187-6
2.             Mahdirejei HA, Peeri M, Azarbayjani MA, Fattahi Masrour F. Fluoxetine combined with swimming exercise synergistically reduces lipopolysaccharide-induced depressive-like behavior by normalizing the HPA axis and brain inflammation in mice. Pharmacol Biochem Behav. 2023;232:173640. doi: 10.1016/j.pbb.2023.173640
3.             Hubbard EA, Motl RW, Elmer DJ. Feasibility and initial efficacy of a high-intensity interval training program using adaptive equipment in persons with multiple sclerosis who have walking disability: study protocol for a single-group, feasibility trial. Trials. 2020;21(1):972. doi: 10.1186/s13063-020-04887-x
4.             Silveira SL, Motl RW, Elmer DJ, Botkin T, Ontiveros T, Williams S, Hubbard EA. Results of a feasibility and initial efficacy clinical trial of a high-intensity interval training program using adaptive equipment in persons with multiple sclerosis who have walking disability. Mult Scler Relat Disord. 2024;87:105695. doi: 10.1016/j.msard.2024.105695
5.             Learmonth YC, Motl RW. Important considerations for feasibility studies in physical activity research involving persons with multiple sclerosis: a scoping systematic review and case study. Pilot Feasibility Stud. 2017;4:1. doi: 10.1186/s40814-017-0145-8
6.             Pilot and Feasibility Studies. Erratum to: Pilot and Feasibility Studies, Vol. 4. Pilot Feasibility Stud. 2017;3:4. doi: 10.1186/s40814-017-0183-2
7.             Boskey AL. Erratum: Bone composition: relationship to bone fragility and antiosteoporotic drug effects. Bonekey Rep. 2015;4:710. doi: 10.1038/bonekey.2015.79
8.             Kolk A, Handschel J, Drescher W, Rothamel D, Kloss F, Blessmann M, Heiland M, Wolff KD, Smeets R. Current trends and future perspectives of bone substitute materials - from space holders to innovative biomaterials. J Craniomaxillofac Surg. 2012;40(8):706-18. doi: 10.1016/j.jcms.2012.01.002
9. Fu Q, Saiz E, Rahaman MN, Tomsia AP. Bioactive glass scaffolds for bone tissue engineering: state of the art and future perspectives. Mater Sci Eng C Mater Biol Appl. 2011;31(7):1245-1256. doi: 10.1016/j.msec.2011.04.022
10. Amouzad Mahdirejei H, Peeri M, Azarbayjani MA, Masrour FF. Diazepam and exercise training combination synergistically reduces lipopolysaccharide-induced anxiety-like behavior and oxidative stress in the prefrontal cortex of mice. Neurotoxicology. 2023;97:101-108. doi: 10.1016/j.neuro.2023.06.004
11. Liu YZ, Li Y, Yu XB, Liu LN, Zhu ZA, Guo YP. Drug delivery property, bactericidal property and cytocompatibility of magnetic mesoporous bioactive glass. Mater Sci Eng C Mater Biol Appl. 2014;41:196-205. doi: 10.1016/j.msec.2014.04.037
12. Baek MH, Ijagbemi CO, O SJ, Kim DS. Removal of Malachite Green from aqueous solution using degreased coffee bean. J Hazard Mater. 2010;176(1-3):820-8. doi: 10.1016/j.jhazmat.2009.11.110
13. Polymeris GS, Giannoulatou V, Kyriakidou A, Sfampa IK, Theodorou GS, Şahiner E, Meriç N, Kitis G, Paraskevopoulos KM. Bioactivity characterization of 45S5 bioglass using TL, OSL and EPR: Comparison with the case of 58S sol-gel bioactive glass. Mater Sci Eng C Mater Biol Appl. 2017;70(Pt 1):673-680. doi: 10.1016/j.msec.2016.09.051
14. Zhu H, Hu C, Zhang F, Feng X, Li J, Liu T, Chen J, Zhang J. Preparation and antibacterial property of silver-containing mesoporous 58S bioactive glass. Mater Sci Eng C Mater Biol Appl. 2014;42:22-30. doi: 10.1016/j.msec.2014.05.004
15. Shankhwar N, Srinivasan A. Evaluation of sol-gel based magnetic 45S5 bioglass and bioglass-ceramics containing iron oxide. Mater Sci Eng C Mater Biol Appl. 2016;62:190-6. doi: 10.1016/j.msec.2016.01.054
16. Wang C, Xie Y, Li A, Shen H, Wu D, Qiu D. Bioactive nanoparticle through postmodification of colloidal silica. ACS Appl Mater Interfaces. 2014 ;6(7):4935-9. doi: 10.1021/am5014858
17. Saravanapavan P, Jones JR, Pryce RS, Hench LL. Bioactivity of gel-glass powders in the CaO-SiO2 system: a comparison with ternary (CaO-P2O5-SiO2) and quaternary glasses (SiO2-CaO-P2O5-Na2O). J Biomed Mater Res A. 2003 ;66(1):110-9. doi: 10.1002/jbm.a.10532
18.          El-Fiqi A, Kim TH, Kim M, Eltohamy M, Won JE, Lee EJ, Kim HW. Capacity of mesoporous bioactive glass nanoparticles to deliver therapeutic molecules. Nanoscale. 2012;4(23):7475-88. doi: 10.1039/c2nr31775c  
New Approaches in Educational Management and Health Sciences
Volume 3, Issue 1
April 2026
Spring 2026
Pages 1-11

  • Receive Date 30 August 2025
  • Revise Date 01 November 2025
  • Accept Date 19 December 2025